3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Burkitt Lymphoma
2
Rhabdoid Tumor
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Medulloblastoma
1
Lymphoma, B-Cell
1
Glioma
1
Ependymoma
1
Diffuse Intrinsic Pontine Glioma
1
Choroid Plexus Carcinoma
1
Central Nervous System Neoplasms
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
55
fludarabine
29
Methotrexate
25
blinatumomab
22
Dexamethasone
22
Cytarabine
21
Vincristine
20
venetoclax
18
fludarabine phosphate
15
Specimen Handling
15
Whole-Body Irradiation
13
Stem Cell Transplantation
11
Biopsy
11
Tacrolimus
10
Prednisone
10
Mycophenolic Acid
10
Mercaptopurine
10
Daunorubicin
10
Thiotepa
9
Rituximab
9
Melphalan
9
Immunotherapy, Adoptive
9
Doxorubicin
8
pegaspargase
7
Magnetic Resonance Spectroscopy
7
Inotuzumab Ozogamicin
7
Granulocyte Colony-Stimulating Factor
7
Cyclosporine
7
Calcium Dobesilate
7
ponatinib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Automobiles
×
Clear all
NCT03938987
2026-02-09
ACIT001/EXC002
University of Alberta
Phase 1/2
Recruiting
63 enrolled